Clinical Trials for Recurrent or Metastatic NSCLC Patients With Classical EGFR Mutations Accompanied by MET Amplification or Overexpression

Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients

NCT ID: NCT06908772

This clinical trial is studying a new treatment for patients with a type of lung cancer called non-small cell lung cancer (NSCLC) who have specific genetic changes known as EGFR mutations along wit...